Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)
The primary aim of this study is to learn about who is most likely to benefit from guided self-help (GSH) for obsessive-compulsive disorder (OCD).
|Study Design:||Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Effectiveness and Neuropsychological Predictors of Guided Self-Help for OCD|
- Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [ Time Frame: Change in Y-BOCS will be assessed over the course of the 17 week treatment trial, then again three months and six months after the treatment. ] [ Designated as safety issue: No ]The Y-BOCS is a semi-structured interview that assesses severity of obsessions and compulsions.
|Study Start Date:||August 2012|
|Estimated Study Completion Date:||August 2015|
|Estimated Primary Completion Date:||August 2015 (Final data collection date for primary outcome measure)|
OCFighter™ s an interactive, internet guided self-help (GSH) treatment program for obsessive-compulsive disorder (OCD). It uses the evidence based approach known as Cognitive Behavioral Therapy (CBT) and was adapted from the previously validated BT STEPS program for OCD. The program teaches the best practice CBT technique to help with OCD called exposure with ritual prevention (ERP).
40 Participants with OCD will be recruited. They will be given access to OC Fighter, an internet OCD treatment program. During the 17 week program, participants will meet with a therapist 9 times. Assessments will occur at pretreatment, post-treatment, 3-month follow up and 6-month follow up.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01659125
|Contact: Gretchen Diefenbach, Ph.D.||860-545-7396||GDiefen@Harthosp.org|
|United States, Connecticut|
|Hartford, Connecticut, United States, 06106|
|Contact: Gretchen Diefenbach, Ph.D. 860-545-7396 GDiefen@harthosp.org|
|Principal Investigator: Gretchen Diefenbach, Ph.D.|
|Principal Investigator:||Gretchen Diefenbach, Ph.D.||Hartford Hospital|